Cargando…
MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer
MicroRNAs (miRNAs) present frequently altered expression in urologic cancers including prostate, bladder, and kidney cancer. The altered expression of miR-223 has been reported in cancers and other diseases in recent researches. MiR-223 is up-regulated in systemic lupus erythematosus and rheumatoid...
Autores principales: | Wei, Yongbao, Yang, Jinrui, Yi, Lu, Wang, Yinhuai, Dong, Zhitao, Liu, Ziting, Ou-yang, Shifeng, Wu, Hongtao, Zhong, Zhaohui, Yin, Zhuo, Zhou, Keqin, Gao, Yunliang, Yan, Bin, Wang, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269886/ https://www.ncbi.nlm.nih.gov/pubmed/25519054 http://dx.doi.org/10.1038/srep07546 |
Ejemplares similares
-
miR-223-5p targeting ERG inhibits prostate cancer cell proliferation and migration
por: Wei, Yongbao, et al.
Publicado: (2020) -
UBC Mediated by SEPT6 Inhibited the Progression of Prostate Cancer
por: Zhang, Ruochen, et al.
Publicado: (2021) -
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
por: Jiao, Peng, et al.
Publicado: (2021) -
miR-223: An Immune Regulator in Infectious Disorders
por: Yuan, Shun, et al.
Publicado: (2021) -
The protective role of miR-223 in sepsis-induced mortality
por: Liu, Dan, et al.
Publicado: (2020)